Elite athletes to take steroids under doctor supervision in landmark safety study

NCT ID NCT07568574

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 60 elite athletes over 5.5 years to see how medically supervised performance-enhancing substances (like testosterone and other anabolic steroids) affect their health and performance. Participants will receive the drugs for up to 25 weeks, then be monitored for five more years. The goal is to understand the safety and tolerability of these substances in a controlled setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Testosterone and other anabolic steroids (testosterone enanthate, cypionate, propionate, gel, Sustanon, methenolone enanthate, nandrolone decanoate)

What this could lead to

If successful, this study could provide data on the long-term safety and performance effects of medically supervised anabolic steroid use in elite athletes.

What could go wrong

This is an early-stage observational study with only 60 participants, so results may not apply broadly. There are known risks from anabolic steroid use, including heart and liver issues.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SAFETY AND IMPACT OF MEDICALLY SUPERVISED PERFORMANCE ENHANCING SUBSTANCE USAGE IN HEALTHY ELITE ATHLETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Trial Site

    Abu Dhabi, United Arab Emirates